NorthStar Medical Radioisotopes announced today the first patient to be treated using the radioisotope Copper-67 (Cu-67) produced from its electron accelerator. According to a release, the administration of the therapeutic…
NorthStar Medical Radioisotopes announced today that it will provide Bayer with its environmentally preferred, non-carrier added (n.c.a.) therapeutic medical radioisotope, actinium‐225 (Ac‐225). “We are very pleased to enter this Ac-225…
NorthStar Medical Radioisotopes has received a custom-built IBA Rhodotron TT 300-HR electron beam accelerator to its new Ac-225 Production facility, the organization announced recently. According to a release, the accelerator…
NorthStar Medical Radioisotopes is collaborating with Inhibrx, a biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, the company announced recently. According to a release, the…
NorthStar Medical Radioisotopes has broken ground on a new facility that will house a planned contract development and manufacturing business unit called Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), the…
NorthStar Medical Radioisotopes has been awarded $37 million in cooperative agreement funds with the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the company announced today. According to a…
NorthStar Medical Radioisotopes and GE Healthcare signed an exclusive agreement for the manufacturing and distribution of iodine-123 (I-123) capsules in the United States, NorthStar announced recently. According to a release,…
NorthStar Medical Radioisotopes has received two custom-built IBA Rhodotron TT 300-HE electron beam accelerators at its facility, the company announced recently. According to a release, the accelerators are critical components…
NorthStar Medical Radioisotopes and Ion Beam Applications (IBA), a provider of proton therapy solutions for the treatment of cancer, expanded its collaboration to increase the global availability of technetium-99m (Tc-99m),…
NorthStar Medical Radioisotopes is making organizational changes to drive focused growth for its therapeutic and specialized single photon emission computed tomography (SPECT) radioisotopes business, the company announced today. “NorthStar is…
